Thimerosal decreases the expression of survivin via the PI3K/Akt pathway. by Wen-Xue Li (189757)

RFD-SF over all participants (A), and for one representative participant (B). by Thomas Jacquet (9960275)

Decreased levels of ubiquitinated proteins in U87MG cells that express PTEN. by Rajaa Errafiy (497050)

Time Course of the RAAS. by Ningning Wang (560944)

“…REN levels increased significantly from baseline at 1-month visit (4.15 ± 7.35 vs. 2.75 ± 8.03 ng/L; DKD vs. non-DKD; between-group difference, <i>p</i> < 0.05), while ARR values decreased significantly from baseline at 1-month visit (−0.70 ± 1.16 vs. −0.59 ± 1.19; between‑group difference, <i>p</i> > 0.05) and 3-month visit (−0.45 ± 1.15 vs. −0.42 ± 1.07; between‑group difference, <i>p</i> > 0.05) in both groups (within‑group change vs. baseline, <i>p</i> < 0.017). …”

Fig 5 - by Kenichi Kiyomoto (12709675)

Spearman correlation analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients. by Ningning Wang (560944)

Effects of chronic PG-LPS infusion on fibrosis in cardiac muscle. by Kenichi Kiyomoto (12709675)

Mean squares and <i>p</i> values from ANOVA of the data for physio-biochemical studies performed on water stressed maize plants treated with foliar sprinkle of ZnSO₄ and... by Qasim Ali (802840)

Experimental procedure and consumption of food and water during chronic PG-LPS infusion in mice. by Kenichi Kiyomoto (12709675)

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Effects of SGLT-2is during the time course. by Ningning Wang (560944)

Effects of chronic PG-LPS infusion on cardiac myocyte apoptosis. by Kenichi Kiyomoto (12709675)

Effects of chronic PG-LPS infusion on Ang II and the weights of cardiac muscle, lung and liver. by Kenichi Kiyomoto (12709675)

Study participant flow. by Daniel J. Bridges (12050007)

Number of individuals enrolled and treated in the CoRE study by arm. by Daniel J. Bridges (12050007)

Results from interrupted time series analyses of confirmed malaria incidence. by Daniel J. Bridges (12050007)

Reverse cumulative plots for each <i>P</i>. <i>falciparum</i> antigen stratified by trial arm. by Daniel J. Bridges (12050007)

Median confirmed population malaria incidence for the entire HFCA (total) or just those identified at the health facility (HF). by Daniel J. Bridges (12050007)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Fig 4 - by Daniel J. Bridges (12050007)